Patent ID: 7482470

Claim:
A compound of Formula I or a stereoisomer or pharmaceutically acceptable salt thereof: wherein: X, Y, X′, Y′, X″, and Y″ are independently selected from: H, C 1-6 alkyl, halogen, CF 3 , O—C 1-6 alkyl, NO 2 , NR 2 , O(CH 2 ) n CO 2 R, OCH 2 CH═CHCO 2 R, CH 2 O(CH 2 ) n CO 2 R, CH 2 OCH 2 CH═CHCO 2 R, O(CH 2 ) n PO(OR) 2 , CH 2 O(CH 2 ) n PO(OR) 2 , NR a (CH 2 ) n CO 2 R, NR a (CH 2 ) n PO(OR) 2 , NR a CH 2 CH═CHCO 2 R, NR a SO 2 R, NR a CO(CH 2 ) n CO 2 R, NR a CO(CH 2 ) n CONR a 2 , O(CH 2 ) n C 6 H 4 CO 2 R, O(CH 2 ) n C 6 H 4 (CH 2 ) n CO 2 R, CH 2 O(CH 2 ) n C 6 H 4 CO 2 R, O(CH 2 ) n C 6 H 4 CONR a 2 , O(CH 2 ) n C 6 H 4 (CH 2 ) n CONR a 2 , O(CH 2 ) n C 6 H 4 -tetrazole, CH 2 O(CH 2 ) n C 6 H 4 CONR a 2 , CH 2 O(CH 2 ) n C 6 H 4 -tetrazole, O(CH 2 ) n C 6 H 4 (CH 2 ) n -tetrazole, NR a (CH 2 ) n C 6 H 4 CO 2 R, CH 2 NR a (CH 2 ) n C 6 H 4 CO 2 R, NR a (CH 2 ) n C 6 H 4 (CH 2 ) n CO 2 R, NR a (CH 2 ) n C 6 H 4 CONR a 2 , CH 2 NR a (CH 2 ) n C 6 H 4 CONR a 2 , NR a (CH 2 ) n C 6 H 4 (CH 2 ) n CONR a 2 ,NR a (CH 2 ) n C 6 H 4 -tetrazole, CH 2 NR a (CH 2 ) n C 6 H 4 -tetrazole, NR a (CH 2 ) n C 6 H 4 (CH 2 ) n -tetrazole, C(NH)NR 2 , (CH 2 ) n C(NH)NR 2 , O(CH 2 ) n CONR 2 , O(CH 2 ) n C(NH)NR 2 , CH 2 O(CH 2 ) n CONR a 2 , NR a (CH 2 ) n CONR a 2 , OCH 2 CH═CHCONR a 2 , CH 2 OCH 2 CH═CHCONR a 2 , NR a CH 2 CH═CHCONR 2 , (CH 2 ) m -tetrazole, O(CH 2 ) n -tetrazole, O(CH 2 CH 2 O) p R, NR a (CH 2 CH 2 O) p R, and SO 2 NHCH 3 ; Z is selected from: H, C 1-6 alkyl, OH, O—C 1-6 alkyl, O(CH 2 CH 2 O) p R, OC(O)—C 1-6 alkyl, O(CH 2 ) n CO 2 R, OCH 2 CH═CHCO 2 R, O(CH 2 ) n PO(OR) 2 , O(CH 2 ) n CONH 2 , O(CH 2 ) n C(NH)NH 2 , OCH 2 CH═CHCONH 2 , O(CH 2 ) n -phenyl-(CH 2 ) m CO 2 R, and O(CH 2 ) n -phenyl-(CH 2 ) m -tetrazole; Q is selected from: H, C 1-6 alkyl, (CH 2 ) n -aryl, (CH 2 CH 2 O) p R, (CH 2 ) n -heteroaryl, (CH 2 ) n -tetrazole, —CHA(CH 2 ) m C(O)NR 2 , CHA(CH 2 ) m CO 2 R, (CH 2 ) n -phenyl-(CH 2 ) m CO 2 R, (CH 2 ) n -phenyl-(CH 2 ) m CONH 2 , and (CH 2 ) m -phenyl-(CH 2 ) m -tetrazole, wherein the heteroaryl, phenyl, and aryl are substituted with 0-3 groups selected from H, C 1-4 alkyl, halogen, CF 3 , O—C 1-4 alkyl, and NO 2 ; M is C═O or SO 2 ; R is independently selected from H, C 1-6 alkyl, C 2-6 alkenyl, and C 2-6 alkynyl; R a is independently selected from H, C 1-6 alkyl, C 2-6 alkenyl, and C 2-6 alkynyl; A is selected from H, C 1-6 alkyl, (CH 2 ) m C 3-6 -cycloalkyl, CH 2 OH, CH(CH 3 )OH, and (CH 2 ) m -phenyl, wherein the phenyl is substituted with 0-3 groups selected from H, C 1-4 alkyl, halogen, CF 3 , O—C 1-4 alkyl, and NO 2 ; p is selected from 2-12; m is selected from 0, 1, 2, and 3; and, n is selected from 1, 2, and 3; provided that at least one of the following is satisfied: (a) at least one of X, Y, X′, Y′, X″, and Y″ is other than H, C 1-6 alkyl, halogen, CF 3 , O—C 1-6 alkyl, NO 2 , and NR 2 ; (b) Z is other than H, C 1-6 alkyl, OH, O—C 1-6 alkyl, acetyloxy, and propionyloxy; or, (c) Q is other than H, C 1-6 alkyl, (CH 2 ) n -heteroaryl, and (CH 2 ) n -aryl.